FT4, FREE THYROXINE
Report
- Report Number
- 1823260-2015-03614
- Event Type
- Malfunction
- Date Received
- June 15, 2015
- Date of Event
- May 21, 2015
- Report Date
- June 15, 2015
- Manufacturer
- ROCHE DIAGNOSTICS
- Product Code
- CEC
- PMA / PMN Number
- K961489
- Removal / Correction Number
- NA
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
THIS EVENT OCCURRED IN (B)(6).
THE CUSTOMER QUESTIONED RESULTS FROM 1 PATIENT SAMPLE TESTED FOR THYROTROPIN (TSH), FREE THYROXINE (FT4) AND FREE TRIIODOTHYRONINE (FT3). THE CUSTOMER PROVIDED THE SAMPLE FOR INVESTIGATION. OF THE DATA PROVIDED, ERRONEOUS FT4 RESULTS WERE IDENTIFIED BETWEEN THE CUSTOMER'S E602 ANALYZER, A CENTAUR ANALYZER, AN E 170 ANALYZER USED AT THE INVESTIGATION SITE AND AN E411 ANALYZER USED AT THE INVESTIGATION SITE. THE DATE OF TESTS PERFORMED AT THE CUSTOMER SITE IS NOT KNOWN. IT IS NOT KNOWN IF ERRONEOUS RESULTS WERE REPORTED OUTSIDE OF THE LABORATORY. REFER TO THE ATTACHED DATA FOR PATIENT RESULTS. NO ADVERSE EVENT WAS REPORTED. THE E 170 ANALYZER SERIAL NUMBER WAS (B)(4). THE E411 ANALYZER SERIAL NUMBER WAS (B)(4). THE FT4 REAGENT LOT NUMBER USED AT THE INVESTIGATION SITE ON THE E 170 ANALYZER WAS 178388 WITH AN EXPIRATION DATE OF 06/30/2015. THE FT4 REAGENT LOT NUMBER USED AT THE INVESTIGATION SITE ON THE E411 ANALYZER WAS 181732 WITH AN EXPIRATION DATE OF 01/31/2016. THE SERIAL NUMBER FOR THE CUSTOMER'S E602 ANALYZER IS NOT KNOWN. A SPECIFIC ROOT CAUSE COULD NOT BE IDENTIFIED. BASED ON THE AVAILABLE DATA, A GENERAL FT4 REAGENT ISSUE CAN MOST LIKELY BE EXCLUDED. WHEN COMPARING VALUES FROM DIFFERENT TYPES OF ANALYZERS, VARIANCES CAN BE EXPECTED. FOR THYROID PARAMETERS, AGE, GENDER AND OTHER PATIENT CHARACTERISTICS SHOULD BE CONSIDERED WHEN COMPARING VALUES.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 387261 | FT4, FREE THYROXINE | RADIOIMMUNOASSAY, FREE THYROXINE | CEC | ROCHE DIAGNOSTICS | NA | ASKU |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |